Can a simple proteomics urine test assist in the early diagnosis of early-stage cancer?

Expert Review of Proteomics

Volumn 8, Issue 5, 2011, Pages 555-557

  Husi, Holger ^a   Fearon, Kenneth C ^b   Ross, James A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

cancer biomarkers; human urine; mass spectrometry; proteomics

Indexed keywords

ADIPOPHILIN; APOLIPOPROTEIN A1; AQUAPORIN 1; BIOLOGICAL MARKER; CALCYCLIN; PEPTIDE; PROTEIN; TUMOR MARKER; UROPLAKIN;

BIOINFORMATICS; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; EARLY CANCER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY CANCER; MASS SPECTROMETRY; METASTASIS; OSTEOSARCOMA; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR BIOPSY; UPPER GASTROINTESTINAL TRACT; URINALYSIS;

EARLY DETECTION OF CANCER; HUMANS; MASS SPECTROMETRY; NEOPLASM STAGING; NEOPLASMS; PROTEOME; TUMOR MARKERS, BIOLOGICAL; URINALYSIS;

EID: 80054775571     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.11.52     Document Type: Review

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74-108 (2005).
2. Gamagedara S, Gibbons S, Ma Y. Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer. Clin. Chim. Acta. 412(1-2), 120-128 (2011).
3. Slupsky CM, Steed H, Wells TH, et al. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin. Cancer Res. 16(23), 5835-5841 (2010).
4. Hoque MO, Begum S, Topaloglu O, et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 64(15), 5511-5517 (2004). (Pubitemid 39006576)
5. Hong CS, Cui J, Ni Z, et al. A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine. PLoS One 6(2), e16875 (2011).
6. Szajda SD, Waszkiewicz N, Chojnowska S, Zwierz K. Carbohydrate markers of pancreatic cancer. Biochem. Soc. Trans. 39(1), 340-343 (2011).
7. Morgan R, Boxall A, Bhatt A, et al. Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clin. Cancer Res. 17(5), 1090-1098 (2011).
8. Li H, Li C, Wu H, et al. Identification of Apo- biomarker for early diagnosis of bladder transitional cell carcinoma. Proteome Sci. 9(1), 21 (2011).
9. Lai Y, Ye J, Chen J, et al. UPK3A: a promising novel urinary marker for the detection of bladder cancer. Urology 76(2), 514.e6-514.e11 (2010).
10. Morrissey JJ, London AN, Luo J, Kharasch ED. Urinary biomarkers for the early diagnosis of kidney cancer. Mayo Clin. Proc. 85(5), 413-421 (2010).
11. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of S100 genes in breast cancer progression. Tumour Biol. 32(3), 441-450 (2011).
12. Husi H, Stephens N, Cronshaw A, et al. Proteomic analysis of urinary upper gastrointestinal cancer markers. Proteomics Clin. Appl. 5(5-6), 289-299 (2011).
13. Wang XH, Zhang LH, Zhong XY, et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Am. J. Pathol. 177(2), 586-597 (2010).
14. Nedjadi T, Kitteringham N, Campbell F, et al. S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br. J. Cancer 101(7), 1145-1154 (2009).
15. Luu HH, Zhou L, Haydon RC, et al. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 229(1), 135-148 (2005). (Pubitemid 41262550)
16. Pine SR, Mechanic LE, Enewold L, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J. Natl. Cancer Inst. 103(14), 1112-1122 (2011).
17. Mischak H, Allmaier G, Apweiler R, et al. Recommendations for biomarker identification and qualification in clinical proteomics. Sci. Transl. Med. 2(46), 46ps42 (2010).
18. Schröder C, Jacob A, Tonack S, et al. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol. Cell Proteomics 9(6), 1271-1280 (2010).